Blood safety in Sub-Saharan Africa: A multi-factorial problem

Transfusion

Volumn 48, Issue 6, 2008, Pages 1256-1261

  Tagny, Claude Tayou ^b   Mbanya, Dora ^a   Tapko, Jean Baptiste ^b   Lefrère, Jean Jacques ^b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

AFRICA; BLEEDING; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNDING; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; MONITORING; PATIENT SAFETY; PLASMA; POVERTY; PREVALENCE; QUALITY CONTROL; REVIEW; SEROLOGY; WORLD HEALTH ORGANIZATION;

AFRICA SOUTH OF THE SAHARA; BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; HUMANS; SAFETY;

EID: 44849099606     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01697.x     Document Type: Review

References (42)

1. UNAIDS/WHO. Global HIV/AIDS and STD. Report on the global HIV/AIDS epidemic. December 2007.
2. O'Brien ME, Kupka R, Msamanga GI, Saathoff E, Hunter DJ, Fawzi WW. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr 2005 40 : 219 25.
3. Don de sang et sécurité transfusionnelle: perspective mondiale. Aide-mémoire n°279, OMS, 2005.
4. Sécurité transfusionnelle et Sida. Collections Meilleures Pratiques. ONU SIDA, 1997.
5. Mbanya D, Takam D, Ndumbe P. Serological finding among first-time blood donors in Yaoundé, Cameroon: is safe donation a reality or a myth? Transfus Med 2003 13 : 1 7.
6. Egah DZ, Banwat EB, Audu ES, Iya D, Mandong BM, Anele AA, Gomwalk NE. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. East Mediterr Health J 2007 13 : 961 6.
7. Diop S, Calattini A, Abah-Dakou J, Thiam D, Diakhate L, Gessain A. Seroprevalence and molecular epidemiology of human T-cell leukemia virus type I (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal. J Clin Microb 2006 44 : 1550 4.
8. The World Health Report 2005: make every mother and child count. Geneva : WHO 2005.
9. Mbanya DN, Kaptue L. Analyse de la prescription sanguine: l'expérience d'un hôpital de Yaoundé, Cameroun. Semaine des Hôpitaux 1995 71 : 873 6.
10. Reduction of maternal mortality: a joint WHO/UNFPA/UNICEF/World Bank Statement. Geneva : World Health Organization 1999.
11. The prevalence of anemia in women: a tabulation of available information. Geneva : World Health Organization 1992 (WHO/MCH/MSM/92.2).
12. World Health Organization. Seventy-Ninth Session, Geneva, 12-23 January 1987 EB79.R1 Blood and blood products. Geneva, Switzerland.
13. AFRO resolution on blood safety resolution: AFR/RC51/R2 adoption of the regional strategy. WHO/AFRO August 2001, Brazzaville Congo.
14. WHO Global Database on Blood Safety, Report 2001-2002.
15. Premier Colloque sur l'organisation de la Transfusion Sanguine dans les pays d'Afrique francophone. Alger : Rapport de l'Etablissement Français du Sang 2006.
16. Tapko JB. The road to safe blood supply in the African region of the World Health Organization: trends and current status: 1999-2006. Africa Sanguine 2007 10 : 1 6.
17. Rapport annuel 2004. Agence Nationale du Sang. Algérie : Ministère de la Santé, de la Population et de la Reforme Hospitalière, République Algérienne Démocratique, 2004.
18. Hensher M, Jefferys E. Financing blood transfusion services in sub-saharan Africa; a role for user fees? Health Policy Planning 2000 15 : 287 95.
19. Mbanya DN, Tayou C. Blood safety begins with safe donations: update among blood donors in Yaoundé, Cameroon. Transfus Med 2005 5 : 395 9.
20. Candotti D, Sarkodie F, Allain JP. Residual risk of transfusion in Ghana. Br J Haematol 2001 113 : 37 9.
21. Field SP, Allain JP. Transfusion in sub-Saharan Africa: does a Western model fit? J Clin Pathol 2007 60 : 1073 5.
22. Medina LA, Kandulu J, Chisuwo L, Kashot A, Mundy C, Bates I. Laboratory costs of a hospital-based blood transfusion service in Malawi. J Clin Pathol 2007 60 : 1117 20.
23. Mvere DA. Perceptions on blood donations in the Africa region. Africa Sanguine 2001 4 : 1 6.
24. Kebede Z. Successful strategies in mobilising voluntary blood donors. Africa Sanguine 2001 4 : 9 11.
25. Loua A, Magassouba FB, Camara M, Haba NG, Balde AM. Bilan de quatre ans de sérologie VIH au Centre National de Transfusion Sanguine de Conakry. Soc Pathol Exot 2004 97 : 139 41.
26. Sentjens RE, Sisay Y, Vrielink H, Kebede D, Ader HJ, Leckie G, Resink HW. Prevalence and risk factors for HIV infection in blood donors and various population sub-groups in Ethiopia. Epidemiol Infect 2002 128 : 221 8.
27. Loua A, Sow EM, Magassouba FB, Camara M, Balde MA. Evaluation of residual infectious risk among blood donors in National Center of Blood Transfusion in Conakry. Transfus Clin Biol 2004 11 : 98 100.
28. Tapko J, Yolande M, Kaptue L. Risque résiduel de transmission du VIH dans les centres de transfusion de Yaoundé. Transfus Clin Biol 1998 5 : 139.
29. Thoai Duong L, Laperche S, Brennan C. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Methods 2004 122 : 185 19.
30. Moore A, Herrera G, Nyamongo J, Lackritz E, Granade T, Nahlen B. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet 2001 358 : 657 60.
31. Koblavi-Dème S, Maurice C, Yavo D, Sibailly TS, N'guessan K, Kamelan-Tano Y, Wiktor SZ, Roels TH, Chorba T, Nkengasong JN. Sensitivity and specificity of HIV rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan, Ivory Coast. J Clin Microbiol 2001 39 : 1808 12.
32. Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005 45 : 133 40.
33. Candotti D, Temple J, Owusu-Ofori S, Allain JP. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods 2004 118 : 39 47.
34. Okocha EC, Ibeh CC, Ele PU, Ibeh NC. The prevalence of malaria parasitaemia in blood donors in a Nigerian teaching hospital. J Vector Borne Dis 2005 42 : 21 4.
35. Erhabor O, Ok O, Awah I, Uko KE, Charles AT. The prevalence of Plasmodia parasitaemia among donors in the Niger delta of Nigeria. Trop Doct 2007 37 : 32 4.
36. Owusu-Ofori S, Temple J, Sarkodie F, Candotti D, Allain JP. Predonation testing of potential blood donors in resource-restricted settings. Transfusion 2005 45 : 1542 3.
37. Nkengasong JN, Janssens W, Heyndrickx L, Fransen K, Ndumbe PM, Motte J, Leonaers A, Ngolle M, Ayuk J, Piot P, van der Groen G. Genotypic sub-types of HIV-1 in Cameroon. AIDS 1994 8 : 1405 12.
38. Peeters M, Gueye A, Mboup S, Bibollet-Ruche F, Ekaza E, Mulanga C, Ouedrago R, Gandji R, Mpele P, Dibanga G, Koumare B, Saidou M, Esu-Williams E, Lombart JP, Badombena W, Luo N, Vanden Haesevelde M, Delaporte E. Geographical distribution of HIV-1 group O viruses in Africa. AIDS 1997 11 : 493 8.
39. Mignonsin D, Abissey S, Vilasco B, Kane B, Bondurand A. Transfusion sanguine en Côte-d'Ivoire: perspectives d'avenir. Médecine d'Afrique Noire 1991 38 : 723 31.
40. Nebie KY, Dahourou H, Hien FM, Meda N, Rouamba A, Sombie I, Soudre BR. Transfusion sanguine au Burkina Faso: modalités de la prescription des produits sanguins au Centre Hospitalier National Souro Sanou (CHNSS) de Bobo-Dioulasso. Bulletin de l'Oceac 1996 34 : 86 9.
41. Tapko SB, Sam O, Diarra-Nama A. Report on the status of blood safety in the WHO African region for 2004. Johannesburg : WHO Regional Office Africa 2005.
42. Mbanya D, Binam F, Kaptue L. Transfusion outcome in a resource-limited setting of Cameroon: a five-year evaluation. Int J Infect Dis 2001 5 : 70 3.